Enhancing autophagy by down-regulating GSK-3β alleviates cisplatin-induced ototoxicity in vivo and in vitro
Enhancing autophagy by down-regulating GSK-3β alleviates cisplatin-induced ototoxicity in vivo and in vitro
复制标题
DOI:
10.1016/j.toxlet.2019.05.025
复制
发表时间:
2019-10-01
影响因子:
3.5
通讯作者:
Xiao, Hongjun
中科院分区:
文献类型:
--
作者:
Liu, Tianyi;Zong, Shimin;Xiao, Hongjun
Previous study reported that either selective GSK-3 beta inhibitor or up-regulating autophagy can alleviate cisplatin-induced ototoxicity. Other studies indicate that the activity of GSK-3 beta is closely associated with the autophagy level. The purpose of this study is to primarily explore the role of autophagy in the alleviation effect of GSK-3 beta inhibition on cisplatin-induced ototoxicity in vivo and in vitro. We observed the autophagy changes induced by GSK-3 beta inhibitor in outer hair cells (OHCs) in a cisplatin-induced ototoxicity rat model. In addition, autophagy inhibitor 3-MA was used in vitro experiments to observe the influence of autophagy inhibition on the cell protection effect due to GSK-3 beta inactivation. The relationship among autophagy, GSK-3 beta and cell damage were inferred. Negative regulation of GSK-3 beta significantly enhanced autophagy and alleviated cisplatin-induced hearing loss, OHC death in vivo and apoptosis in vitro. The autophagy inhibitor 3-MA inverted the protective effect of negative regulation of GSK-3 beta. These results indicated that enhancing autophagy may be a key downstream effect of GSK-3 beta inhibition in the alleviation of cisplatin-induced ototoxicity both in vivo and in vitro.